AMAG - AMAG Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue609,946532,091418,276
Cost of Revenue183,166116,88988,501
Gross Profit426,780415,202329,775
Operating Expenses
Research Development75,01766,08442,878
Selling General and Administrative259,933249,870160,309
Non Recurring385,09120,37815,368
Others---
Total Operating Expenses---
Operating Income or Loss-293,26178,870111,220
Income from Continuing Operations
Total Other Income/Expenses Net-8,4513,338-18,125
Earnings Before Interest and Taxes-301,71282,20893,095
Interest Expense68,38273,15353,251
Income Before Tax-370,0949,05539,844
Income Tax Expense-170,86611,5387,065
Minority Interest---
Net Income From Continuing Ops-199,228-2,48332,779
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-199,228-2,48332,779
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-199,228-2,48332,779